Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Revista Romana de Medicina de Laborator
Volume 32 (2024): Issue 1 (January 2024)
Open Access
Challenges in prophylactic therapy with Emicizumab in patients with hemophilia A: Focus on monitoring tests
Melen Brinza
Melen Brinza
,
Valentina Uscatescu
Valentina Uscatescu
,
Mihai Hemcinschi
Mihai Hemcinschi
,
Elisabeta Chiriac
Elisabeta Chiriac
,
Georgiana Gherghe
Georgiana Gherghe
and
Daniel Coriu
Daniel Coriu
| Jan 29, 2024
Revista Romana de Medicina de Laborator
Volume 32 (2024): Issue 1 (January 2024)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jan 29, 2024
Page range:
93 - 100
Received:
Nov 01, 2023
Accepted:
Dec 04, 2023
DOI:
https://doi.org/10.2478/rrlm-2024-0003
Keywords
hemophilia A
,
inhibitors
,
Emicizumab
© 2024 Melen Brinza et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.